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In silico data mining of large-scale databases for the virtual 
screening of human interleukin-2 inhibitors
Interleukin-2 (IL-2) is involved in the activation and differ-
entiation of T-helper cells. Uncontrolled activated T cells 
play a key role in the pathophysiology by stimulating 
 inflammation and autoimmune diseases like arthritis, psori-
asis and Crohn’s disease. T cells activation can be sup-
pressed either by preventing IL-2 production or blocking 
the IL-2 interaction with its receptor. Hence, IL-2 is now 
emerging as a target for novel therapeutic approaches in 
several autoimmune disorders. This study was carried out 
to set up an effective virtual screening (VS) pipeline for IL-2. 
Four docking/scoring approaches (FRED, MOE, GOLD and 
Surflex-Dock) were compared in the re-docking process to 
test their performance in producing correct binding modes 
of IL-2 inhibitors. Surflex-Dock and FRED were the best in 
predicting the native pose in its top-ranking position. 
Shapegauss and CGO scoring functions identified the 
known inhibitors of IL-2 in top 1, 5 and 10 % of library and 
differentiated binders from non-binders efficiently with 
 average AUC of > 0.9 and > 0.7, resp. The applied docking 
protocol served as a basis for the VS of a large database that 
will lead to the identification of more active compounds 
against IL-2.
Keywords: IL-2, virtual screening, FRED, MOE, GOLD, 
Surflex-Dock, ROC-curves
Interleukin-2 (IL-2) is a cytokine that is predominantly involved in the growth, activa-
tion, and differentiation of T-helper 1 (Th1) cells. Binding of IL-2 with its trimeric receptor 
(known as IL-2R) causes proliferation and clonal expansion of activated T-cells (1). The 
trimeric IL-2R is composed of α (IL-2Rα), β (IL-2Rβ) and γ (IL-2Rγ) subunits. Aberrant Th1 
immune response leads to graft rejection. Moreover, several autoimmune disorders like 
inflammatory bowel disease (Crohn’s disease and ulcerative colitis) and psoriasis are 
linked with the abnormal Th1 immune responses (2). An elevated level of IL-2 in serum is 
also seen in scleroderma, gastric and non-cell lung cancer, rheumatoid arthritis and several 
neoplastic diseases (3). Thus, IL-2 is a considerable therapeutic target for the treatment of 
these diseases. Current therapies target the IL-2 production/IL-2 signaling pathway to 
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 develop new immuno-modulators. Specific inhibition of IL-2 interaction with its receptor 
(IL-2Rα) by antibodies and general immuno-modulators inhibit the Th1 response without 
causing toxicity (4). However, antibodies have shown several drawbacks such as lack of 
oral bioavailability and high cost. Designing a specific inhibitor of IL-2 production that 
blocks direct interaction of IL-2 with IL-2Rα could offer a significant improvement in 
 immunosuppressive therapy. Thus far, the discovery of small molecule inhibitors of IL-2 
or other proteins that are involved in protein-protein interactions has been challenging (5).
Computational drug design approaches have been applied successfully in the devel-
opment of new drugs at a lower cost and less screening time for different drug targets that 
are challenging (6). Pertaining to our interest in the computational analysis of immuno-
modulators targeting IL-2 and other cytokines (7–13), we have conducted a comparative 
analysis of docking/scoring methods to develop the most effective virtual screening (VS) 
pipeline for the screening of large scale data against IL-2. Hence, four docking programs 
with different algorithms and scoring functions: FRED (14, 15), GOLD (16), Surflex-Dock 
(17) and MOE (18, 19) were extensively evaluated in this study. The selected programs were 
evaluated based on two criteria: the ability of docking programs to produce exactly similar 
conformations (pose or solution) of ligands to their native (experimentally characterized) 
conformation, their accuracy in the selection and identification of known active inhibitors 
implanted in the database of decoys (inactive compounds or compounds whose activities 
are not determined). The decoy set was selected from the ZINC database (20). Statistical 
analysis (enrichment factor and ROC-curves) was applied to VS results. The study resulted 
in the identification of an effective docking method that will be used for the multiple tasks 
of designing IL-2 inhibitors in the future.
EXPERIMENTAL
In this study, we have employed four docking programs, i.e., MOE v2006.08 (Molecular 
Operating Environment) obtained from Chemical Computing Group ULC, Montreal, 
 Canada (18), FRED (Fast Rigid Exhaustive Docking) taken from OpenEye Scientific Software 
Inc., Surflex-Dock (implemented in SYBYL v7.3) (21), and GOLD v3.2, (Genetic Optimization 
for Ligand Docking) obtained from Cambridge Crystallographic Data Center, University 
of Cambridge, UK (22).
The entire in silico experiments were performed on quad-core Intel 3.0 GHz Xeon 
Linux work station running under SUSE 11.0 operating system. Because docking speed is 
very important in the screening of huge datasets, computational (CPU) time of each docking 
method was recorded. FRED and Surflex-Dock took < 1 minute to dock one compound, 
whereas MOE and GOLD used 1–2 minutes for docking.
Selection and preparation of protein-ligand files for docking
Protein-ligand complexes were chosen for docking with special care. Flexibility in the 
protein structures was considered, and three human IL-2 X-ray structures in complex with 
ligands were downloaded from Protein Data Bank [PDB IDs: 1M48 (27), 1PW6 (28) and 1PY2 
(28)] for the assessment of docking methods. The chemical structures of the co-crystallized 
ligands (so-called reference ligands) are shown in Table I. The protein-ligand complexes 
were selected based on the following criteria: protein structure should be of human origin, 
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structure of protein should have good resolution (≤ 3.0 Å), protein-ligand interaction should 
be non-covalent and their experimental inhibitory concentrations (IC50) must be reported.
For docking, protein and ligand’s coordinate files were prepared by SYBYL7.3. All 
heteroatoms other than the ligand were removed. Water molecules within 3.0 Å of ligand 
were retained, the rest were removed from protein. On each protein, protons were added 
by the SYBYL biopolymer module. The co-crystallized ligands were extracted from their 
respective protein and saved as a reference structure for the comparison with their docked 
conformation and RMSD calculation. The atom and bond type of each ligand was rectified, 
protons were added to ligand molecules according to their protonation states and Gasteiger- 
-Hückel charges were assigned. Finally, ligands coordinates were minimized by Tripos 
Force Field (1000 steepest descent steps) (29). The ionizable groups of ligands were protonated 
according to their physiological pH.
Docking methods
MOE 2009. – Initially, the MMFF94 force field (30, 31) was applied to minimize the 
protein structure until the RMSD gradient of 0.05 kcal mol–1 Å–1. The active site was de-
fined by the co-crystallized ligand. MOE possesses different docking algorithms including 
alpha PMI, alpha triangle, proxy triangle and triangle matcher, and four scoring functions: 
ASE, alpha HB, affinity dG, and London dG. Each docking method of MOE was applied in 
combination with each scoring function of MOE. Thus, sixteen docking-scoring methods 
were used in MOE (19) to recognize the most suitable method for IL-2. Finally, thirty 
docked poses from each combination were saved for further study.
Surflex-dock. – Surflex-dock implies hammerhead incremental construction (HIC) as 
docking engine (26) and empirical scoring function that includes hydrophobic and charged 
complementarity terms. HIC basically creates a pseudo-binding site which is known as 
protomol (17). Ligand is fragmented and fragments are aligned over protomol in order to 
generate poses that maximize molecular complementarity with the binding site. By HIC 
and a crossover, distinct poses are combined to generate a full molecule from aligned frag-
ments which are scored by scoring function (17).
Docking is started with the generation of Protomol which depends on Proto_bloat and 
Proto_thresh parameters that define the active site. Proto_bloat describes how far from a 
potential ligand the site should extend, while Proto_thresh describes how deep into the 
protein the atomic probes used to define the protomol can penetrate. The default para-
meters for threshold and bloat are 0.50 and 0 Å, resp. By default, 30 orientations of each 
ligand were retained.
GOLD 3.2. – GOLD applies genetic algorithm (16) that offers full and partial conforma-
tional flexibility to ligand and protein, resp. The scoring function of GOLD includes the 
terms of hydrogen-bonding, vdW, and intra-molecular energies. vdW interactions of protein- 
-ligand complex are described by 8–4 potential while ligand steric energies are described by 
12–6 potential. For docking, active site was created around 10 Å of ligand. Docking para-
meters were set as 10 genetic algorithm (GA) run, 100,000 maximum number of operations 
and population size of 50 individuals. Operator weights for crossover, mutation, and migra-
tion were set to 95, 95, and 10, resp. The distance between fitting points and hydrogen donors 
was 4.0 Å. The non-bonded vdW energies cut-off was 2.5 Å. During docking, four scoring 
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functions: GoldScore, Astex Potential (ASP), ChemScore (GOLD_CS), and ChemPLP (22) 
were tested in separate runs. Thirty docked poses were saved for each ligand.
FRED 2.2.5. – FRED (14, 15) applies rigid docking by using exhaustive searching and 
has different scoring functions. An ensemble of rigid body poses is generated for each com-
pound within the binding site, and these poses are passed against the negative image of 
active site. Poses clashing with this ‘bump map’ are eliminated. During docking, Gaussian 
shape function is used to score and rank those docked poses that are retained after shape 
fitting. FRED uses a prepared receptor file and a multi-conformer library of ligands which 
is generated by OMEGA (32). MMFF94s force field was applied with the dielectric constant 
of 4.0. FRED receptor 2.2.5 was used to prepare the receptor files by a shape-based site detec-
tion algorithm. The contours were created on the bound ligand that limits the search space 
to the volume enclosed by the bound ligand. Docked conformation of ligands was scored 
by nine scoring functions, i.e., Chemgauss 2 (CG2), Chemgauss 3 (CG3) (15), ChemScore 
(FRED_CS) (23), Chemical Gaussian overlay (CGO), Chemical Gaussian Tanimoto (CGT) 
(15), Piecewise Linear Potential (PLP) (24), ScreenScore (SS) (25), Shapegauss (SG), and 
OEChemScore (OECS). For each ligand thirty docked poses were saved by default.
Virtual screening. – For virtual screening (VS), a set of 9.0 million drug-like compounds 
was selected from ZINC database (20). FILTER (34, 35) was used for further filtration of 
library according to Lipinski rule of five (33). 1,594,931 (approx. 1.5 million) compounds 
passed the filter criteria, among them 10,000 compounds were selected for VS. For enrich-
ment purpose, 91 known inhibitors of IL-2 were selected from literature review (36–40). 
Their 3D-coordinates were generated by MOE. The molecular structures of known actives 
are presented in Table II. The known active inhibitors were seeded into the library of 10,000 
decoys, and a set 10,091 molecules was imported into MOE database. The geometry of each 
compound in library was optimization by protonate-3D command of MOE.
Analysis measures. – By re-docking tests, we checked the ability of each docking method 
to predict accurate binding mode of reference ligands. By enrichment studies, scoring 
functions were scrutinized in the identification of known inhibitors among decoys.
Cognate ligand docking accuracy. – Root mean square deviation (RMSD) is usually cal-
culated between the docked and un-docked conformation of cognate ligand to assess the 
predictive ability of docking algorithm. In this study, the following criteria were used: first 
ranked (top) solution with RMSD ≤ 2.0 Å was termed as ‘good’, top ranked conformation 
with RMSD 2.0–3.0 Å was regarded as ‘fair’, top ranked orientation with RMSD > 3.0 Å, or 
an inverted or incorrect position, was termed as ‘inaccurate’.
Virtual screening accuracy. – By using enrichment factor (EF) and ROC curves, the effec ti-
veness of scoring functions was assessed. EF is widely used metric for the comparison of 
VS results; it was calculated by Eq. 1. Scoring functions which correctly ranked 50 % of 
known inhibitors in top 1, 5 and 10 % of docked library, were considered successful.
 Enrichment factor






Ntotal – total number of compounds in the database, Nsampled – number of ligands in the 
docked database to be examined, HITStotal – total number of active compounds, HITSsampled 
– number of active inhibitors found in top Nsampled ligands of docked library.
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Percentual enrichment factor (%EF) for each scoring function was calculated by Eq. 2:
 Enrichment factor %
Enrichment factor
Ideal enrichment factor
( ) = × 100  (2)
Receiver operating characteristic curves (ROCs). – Structure-based VS and molecular 
modeling methods are routinely evaluated by ROC curves (41). It effectively differentiates 
between two populations, so it is suited for evaluating VS performance. Discrimination 
between active and decoy compounds are important issue. ROC curve describes the trade-off 
between sensitivity (detection of true positives by model) and specificity (ability of model 
to avoid false negatives and positives). Enrichment is quantified by calculating area under 
the curve (AUC). If the value of AUC is ≥ 0.9, the scoring function was considered as excellent, 
while the value of AUC ≤ 0.6 depicts least or no enrichment.
RESULTS AND DISCUSSION
Virtual screening is incomplete without molecular docking; especially when a 3D- 
structure of drug target is available docking is most commonly applied VS tool (6). Dock-
ing is based on two critical steps. In the first step, docking algorithms perform conforma-
tional sampling of small molecules to place them in the 3D-binding site of receptor/
proteins. In the second step, scoring functions calculate the binding affinity of each con-
formation of docked ligand within the binding site. The binding affinities are estimated in 
terms of scores or binding free energy. Scoring functions must differentiate correct bind-
ing states of ligands with the non-native docked conformation during docking and should 
identify known potential inhibitors (active molecules) within the library of inactive com-
pounds with reasonable accuracy and speed (42).
Several studies have been conducted to evaluate docking/scoring methods that pri-
marily focused on pose prediction of ligands and VS. For selected drug targets, pose pre-
diction accuracy has been successfully achieved. However, the scoring functions need 
more improvement to successfully predict the true binding affinity of a ligand for its receptor. 
Additionally, all the docking methods occasionally manifest false negative and false positive 
results. Therefore, it is challenging to improve the strength of docking methods in view of 
structural and energetic prediction.
Furthermore, it is difficult to generalize a particular docking method for all the drug 
targets because a particular docking set up may work better for certain drug targets or 
compounds classes than for others. Therefore, it is highly recommended to validate a 
docking method before conducting VS against specific target of interest. This study was 
conducted in order to establish effective and appropriate VS protocol for the data mining 
of IL-2 inhibitors.
Validation of docking programs
The success of VS depends on the accurate prediction of protein-ligand interactions 
(42, 43). For this purpose, a docking tool is required that generates suitable conformation 
of ligand within the protein binding site. The quality of interaction is governed by reliable 
energetic evaluation and the docking accuracy is validated by the RMSD values between 
crystal structures and predicted docked poses.
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Table II. Chemical structures of known inhibitors
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To scrutinize the docking accuracy, three IL-2 structures in complex with known 
 inhibitors were retrieved, namely, 1M48, 1PW6 and 1PY2 with the cognate ligand FRG, FRB 
and FRH, resp. The IC50 values, resolution of X-ray structures, rotatable bonds and log P 
values of ligands are tabulated in Table I. The structures of selected known ligands are 
shown in Table II. The top ranked docked poses of each ligand are shown in Figs. 1–3, 
while their RMSDs are tabulated in Table III.
1M48. – The known inhibitor 2-[3-methyl-4-(N-methyl-guanidino)-butyrylamino]-
3-(4-phenylethynyl-phenyl)-propionic acid methyl ester (ligand ID: FRG) was taken from 
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Fig. 1. Docked poses of 1M48, generated by: a) MOE (Molecular Operating Environment), b) GOLD 
(Genetic Optimization for Ligand Docking), c) FRED (Fast Rigid Exhaustive Docking) and d) Surflex 
Dock. The experimental and docked conformations are presented in yellow and green stick model, 
resp.
Fig. 2. Docked poses of 1PW6 generated by: a) MOE (Molecular Operating Environment), b) GOLD 
(Genetic Optimization for Ligand Docking), c) FRED (Fast Rigid Exhaustive Docking) and d) Surflex 
Dock. The experimental and docked conformations are presented in yellow and green stick model, 
resp. 
protein 1M48 and re-docked into the receptor (IL-2R) binding site of IL-2 by all the docking 
methods used in this study (Table III). In MOE, TM and AT were able to generate good 
pose when used with LdG scoring function, while APMI and PT with LdG failed to gene-
rate good pose. APMI and PT predicted docked solution was in inverted position. TM with 
a)                                    b)                                      c)                                    d)
a)                                    b)                                      c)                                       d)
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ASE depicted good binding mode of this compound as compared to other MOE algo-
rithms. APMI, AT and PT with ASE were unsuccessful to produce good pose. The docked 
conformation of the compound was inverted by 180 °. TM, AT, APMI, and PT showed poor 
performance when used with AdG and their predicted RMSDs were ≥ 10 Å. It was observed 
that each algorithm produced the conformation with < 2.0 Å within thirty poses, which 
was not ranked accurately in top position. It reflects that the docking program faced dif-
ficulty to correctly rank the correct pose in the top position. When applied with AHb, TM 
and PT showed top ranked best poses, while AT and APMI were unsuccessful. It indicates 
that the combination of TM and AT algorithms with LdG, and TM and PT algorithms with 
AHb, are able to generate good poses. The docked views of 1M48 generated by MOE, 
FRED, GOLD and Surflex-Dock are shown in Fig. 1.
Surflex-Dock performed well in the prediction of good pose in top ranked position 
(Fig. 1). In GOLD, four scoring functions (ASP, ChemPLP GOLD_CS, and GOLD score) 
were used. Each scoring function of GOLD produced docking solution with RMSD < 1.2 Å 
(Table III) and showed excellent agreement with the crystal structure. In FRED, nine 
scoring functions (CG2, CG3, FRED_CS, OECS, SG, SS, CGO, CGT and PLP) were used that 
depicted good poses of ligand in the top ranked solution.
1PW6. – The ligand FRB is complexed in 1PW6 which possesses eleven rotatable 
bonds. Usually, docking methods fail to produce good solutions of highly flexible ligands. 
The re-docking performance of MOE was declined and the combination of APMI, PT and 
TM with LdG showed unsatisfactory results, and showed inverted conformation in top 
ranked position. It indicates that these methods could not handle ligands with > 10 rota-
table bonds. AT generated docked pose in appropriate orientation, however, due to high 
flexibility, the compound was deviated from its X-ray conformation. As a result, RMSD 
Fig. 3. Docked poses of 1PY2 generated by: a) MOE (Molecular Operating Environment), b) GOLD 
(Genetic Optimization for Ligand Docking), c) FRED (Fast Rigid Exhaustive Docking) and d) Surflex 
Dock. The experimental and docked conformations are presented in yellow and green stick model, 
resp.
a)                            b)                                                          c)                            d)
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Table III. The docking performance of MOE, GOLD, FRED and Surflex-dock in the prediction of good 
conformation in a top-ranking position
1M48 1PW6 1PY2
Score RMSD Score RMSD Score RMSD
MOE
TM_LdG –10 1.3 –12 6.19 –12 2.87
APMI_LdG –7 10.5 –6 3.21 2 9.40
AT_LdG –10 1.26 –10 12.97 –10 9.61
PT_LdG –10 11.60 –11 7.94 –13 5.11
TM_ASE –8 2.04 –11 3.73 –10 13.19
APMI_ASE –10 10.29 –12 11.47 –19 14.56
AT_ASE –7 10.57 –11 11.24 –13.50 13.56
PT_ASE –7 10.63 –9 11.66 –12.94 4.73
TM_AdG –3 12.24 –3 11.28 –2 14.74
APMI_AdG 5 10.47 22 9.39 –60.93 9.40
AT_AdG –3 11.47 –4 17.19 –3.14 15.74
PT_AdG –4 12.24 –3 11.28 –5.94 7.07
TM_AHB –100 1.3 –58 11.28 –97 5.71
APMI_AHB –50 10.47 –86 2.81 –11.7 7.73
AT_AHB –54 10.92 –68 10.92 –76.83 19.60
PT_AHB –100 1.29 –89 11.73 –120.5 2.86
GOLD
GOLD_Score 73 0.87 82 0.87 68 14.44
GOLD_CS 37 0.79 37 0.78 29 14.63
ASP 38 0.91 43 0.85 38 14.74
ChemPLP 86 1.12 90 0.80 87 14.97
FRED
SG –299 1.84 –362 2.3 –347 2.26
SS –140 1.84 –153 2.3 –127 2.26
PLP –64 1.84 –57 2.3 –47 2.26
OECS –44 1.84 –34 2.3 –31 2.26
FRED_CS –26 1.84 –14 2.3 –4.41 2.26
CG3 –38 1.84 –36 2.3 –16.06 2.26
CG2 –53 1.84 –50 2.3 –49.4 2.26
CGO –46 1.84 –56 2.3 –48 2.26
CGT –54 1.84 –59 2.3 –47 2.26
SurflexDock
Hammerhead 5.80 1.32 5.54 1.46 8.62 0.67
AdG – affinity dG, AHB – alpha HB, APMI – alpha PMI, ASP – Astex Statistical Potential, AT – alpha triangle, CG2 
– Chemgauss2, CG3 – Chemgauss3, FRED – Fast Rigid Exhaustive Docking, FRED_CS – ChemScore, GOLD – Ge-
netic Optimization for Ligand Docking, GOLD_CS – ChemScore, LdG – London dG, OECS – OEChemScore, PLP 
– piecewise linear potential, PT – proxy triangle, SG – Shapegauss, SS – ScreenScore, TM – triangle matcher
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became > 3.0 Å. Similarly, ASE with TM produced top ranked conformation with RMSD < 
4.0 Å. The re-docking results of all the algorithms with AdG were similar to the results 
obtained in the case of 1M48. Similarly, AHb in combination with TM, AT and AT did not 
produce significant results, while docking poses generated by APMI in combination with 
AHb fell into fair category (RMSD > 2.0 and ≤ 3.0 Å).
During re-docking, all the scoring functions of GOLD produced conformation of FRB 
with RMSD < 1.0 Å (Fig. 2), while Surflex-Dock generated the docked pose of FRB with 
RMSD ≤ 1.5 Å. Thus, we can assume that GOLD and SurflexDock are able to generate good 
conformation of highly flexible ligand (with ≤15 RBs). FRED also produced good orienta-
tion of FRB in its top ranked conformation (RMSD < 2.3 Å). These results suggest that 
GOLD, FRED and Surflex-Dock are appropriate for the surface binding protein like IL-2.
1PY2. – 1PY2 is co-crystallized with the most active inhibitor FRH (IC50 = 0.060 
µmol L–1) which possesses 15 RBs. The re-docking result of FRH is shown in Fig. 3. The 
re-docking results of MOE were the same as observed in 1M48 and 1PW6. When applied 
with LdG, APMI, AT and PT did not give significant results, however, TM depicted ‘fair’ 
conformation. The increase in the flexibility of ligand is the main reason of insignificant 
performance of MOE. TM also produced ‘wrong’ conformation when used with ASE. The 
performance of APMI, AT and PT remained the same and these scoring functions failed 
Table IV. Percent enrichment factor (%EF) calculated for 11 scoring functions over three protein-ligand 
complexes
FRED GOLD Surflex-Dock
CGO CGT CG2 CG3 FRED_CS OECS SS SG PLP Gold_score
SD_
score
1M48 Enrichment factor (%)
1 % 51.65 6.59 24.18 4.40 12.09 41.76 15.38 76.92 28.57 28.57 0.11
5 % 61.54 14.28 31.87 6.59 16.48 50.55 21.98 81.32 43.96 37.36 26.37
10 % 65.93 24.17 34.06 9.89 19.78 63.74 26.37 81.32 51.65 46.15 31.87
1PW6 Enrichment factor (%)
1 % 72.53 38.46 42.86 1.10 17.58 37.36 4.39 71.43 10.99 5.49 3.30
5 % 73.63 54.94 59.34 2.20 20.88 50.55 27.47 76.92 27.47 17.58 17.58
10 % 73.63 64.84 64.83 3.30 24.17 58.24 36.26 76.92 40.66 25.27 32.53
1PY2 Enrichment factor (%)
1 % 67.03 31.87 63.74 6.59 17.58 52.75 21.98 79.12 32.97 5.49 7.69
5 % 79.12 50.55 79.12 15.38 17.58 68.13 50.55 84.61 59.34 15.38 16.48
10 % 80.22 56.04 81.319 19.78 28.57 73.63 21.98 87.91 71.43 19.78 26.37
CGO – Chemical Gaussian Overlay, CGT – Chemical Gaussian Tanimoto, CG2 – Chemgauss2, CG3 – Chemgauss3, 
FRED – Fast Rigid Exhaustive Docking, GOLD – Genetic Optimization for Ligand Docking, OECS – OEChemScore, 
PLP – piecewise linear potential, SS – ScreenScore, SG – Shapegauss.
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to rank good docking pose as top ranked solution. AdG in combination with all the dock-
ing algorithms was unable to find good pose. The RMSD was in the range of 7.0 to 16.0 Å. 
When applied with AHb, APMI, AT and TM AdG failed to generate good pose, while PT 
was able to generate fair docked poses with RMSD 2.86 Å.
From the re-docking conducted on three protein-ligand complexes, it can be concluded 
that the re-docking performance of MOE is relatively less accurate as compared to other 
docking programs. Some of the docking algorithms resulted with good RMSD with parti-
cular scoring function, however, results were inconsistent. For instance, TM performed 
well with LdG and predicted good and fair conformations of 1M48 and 1PY2 but failed to 
reproduce good/fair pose of 1PW6. Similarly, PT returned with good and fair pose of 1M48 
and 1PY2, resp., when used with AHb. It can be concluded that parameter optimization 
can lead to enhanced prediction ability. As observed previously, the top ranked docked 
pose of Surflex-Dock was in good agreement with the experimental data. Surflex-Dock 
returned with good poses of all three ligands used in this study. Among all the docking 
programs, the performance of Surflex-Dock was the best when generating the poses with 
RMSD < 1.5 Å.
GOLD failed to generate either good or fair pose of FRH when used with ASP, ChemP-
LP, GOLD_CS, and GOLD scoring function. Hence, the docking accuracy of these scoring 
functions drastically dropped and resulted in RMSD > 10 Å, reflecting that these scoring 
functions are unable to correctly dock highly flexible molecule.
The FRED predicted top ranked docked pose falls into fair category. The docked 
 conformation was superimposed on the reference ligand, however, the orientation of the 




CGO 0.764 0.760 0.859 0.794
CGT 0.558 0.697 0.755 0.670
CG2 0.475 0.790 0.905 0.723
CG3 0.334 0.202 0.497 0.494
FRED_CS 0.374 0.480 0.549 0.468
OECS 0.762 0.754 0.845 0.787
SS 0.562 0.594 0.770 0.642
SG 0.936 0.878 0.952 0.922
PLP 0.766 0.622 0.836 0.741
GOLD score 0.786 0.653 0.597 0.679
Surflex score 0.666 0.567 0.546 0.593
CGO – Chemical Gaussian Overlay, CGT – Chemical Gaussian Tanimoto, CG2 – Chemgauss2, CG3 – Chemgauss3, 
FRED–CS – FREDChemScore, OECS – OEChemScore, PLP – piecewise linear potential, ROC–curve – receiver 
 operating characteristics curve, SS – ScreenScore, SG – Shapegauss. Qualitative interpretation of the area under 
ROC curve is as follows: fail: 0.0–0.6, poor: >0.6–0.7, fair: >0.7–0.8, good: >0.8–0.9, excellent: >0.9–1.0.
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 flexible alkyl chain at terminal guanidinium moiety is tilted 80°, causing the increase in 
RMSD. 
The re-docking experiments revealed that docking methods faced difficulty to handle 
highly flexible ligands because of the increased number of possible conformations due to 
Fig. 4. ROC curve for: a) 1M48, b) 1PW6 and c) 1PY2 (CGO – Chemical Gaussian Overlay, CGT – Chem-
ical Gaussian Tanimoto, GOLD – Genetic Optimization for Ligand Docking, PLP – piecewise linear 
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increased number of rotatable bonds, thus affecting docking accuracy. Hence, docking 
performance of Surflex-Dock, GOLD with GOLD score and FRED was encouraging, while 
MOE was neither able to generate good poses in thirty conformations nor, if generated, 
those conformations were placed in top ranked solutions.
Virtual screening (VS) accuracy. – In this step, only those docking/scoring methods were 
used that performed well in re-docking or pose selection step. Hence, Surflex-Dock, 
GOLD_score, and FRED were selected. To scrutinize VS accuracy, 10,000 compounds were 
selected from ZINC database and 91 known actives were embedded in 10,000 molecules. 
A set of 10,091 compounds was prepared and docked into each receptor (1M48, 1PW6 and 
1PY2) by GOLD, Surflex-Dock and FRED. The ability of scoring methods to effectively dif-
ferentiate between active ligands and decoys and to rank known inhibitors in top of 
screening list was assessed by enrichment factor (%EF) which was calculated for each 
scoring function in top 1, 5 and 10 % of the database screened. The purpose was to iden-
tify those scoring functions which have ability to correctly score at least 50 % of the active 
compounds at the top of their scoring order.
The optimal threshold for the VS accuracy was justified by the following criteria: if in 
top 1 % (top 100 compounds), in top 5 % (top 500 compounds) and in top 10 % (top 1000 
compounds) all the 91 active compounds are successfully identified, then the ideal enrich-
ment factor would be 100, 20, and 10, resp.
1M48. – The EF of 11 scoring functions on 1M48 is tabulated in Table IV. All scoring 
methods identified active compounds in the decoys set. CGO and SG showed 51 and 76 % 
for %EF, resp., in top 1% of the screened library, whereas CGT, CG3, and Surflex-Dock score 
identified only 6, 4 and 0.1 active compounds in top 1 % list, resp. FRED_CS and SS have 
similar performance, with 12 and 15 enrichment, resp. The performance of CG2, PLP and 
GOLD score was similar with %EF of 24, 28 and 28 %, resp. The performance of CG2 was 
better than its newer version CG3. The performance of OECS was also good in identifying 
the known actives, with 41 % enrichment. OECS achieved better enrichment as compared 
to FRED_CS. SG achieved better enrichment in top 5 % of the screened database. The %EF 
of SG and CGO was 81 and 61 %, resp. The performance of Surflex score improved drasti-
cally and 26 % active compounds were identified in the top 5 % of the screened database, 
while CGT, CG2, CG3, FRED_CS, SS and GOLD score showed 14, 31, 6, 16, 21 and 37 % 
enrichment, resp., in top 5 % of database. OECS and PLP placed 50 and 43 % active com-
pounds, resp., in 5 % list. In 10 % of the screened database, CGO showed 65 % enrichment; 
CGT, CG2, FRED_CS, SS and Surflex score identified 24, 34, 19, 26 and 31 % active com-
pounds, resp. The overall performance of CG3 was not encouraging; it identified only 9 % 
active compounds in the top 10 % of the screened database. The performance of GOLD 
score was improved with 46 % enrichment. PLP correctly identified 51 % active com-
pounds, while OECS achieved 63 % enrichment in top 10 % of ranked library. CGO and 
OECS identified 50 % active compounds in top 5 % screened library.
1PW6. – In 1PW6, CGO and SG accurately identified 72 and 71 % active compounds in 
top 1 % of ranked database, resp., while other scoring functions showed < 50 % enrichment 
in this list. CG3, Surflex score, SS and GOLD score identified < 6 % known inhibitors in top 
1 % library, while PLP and FRED_CS identified 10 and 17 % known actives in top 1 % of 
database screened, resp. OECS, CGT and CG2 showed 37, 38 and 42 % enrichment, resp. 
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The performance of GOLD score and Surflex score was improved with 17 % enrichment in 
top 5 % of screened library. The performance of FRED_CS, SS and PLP was consistent as 
observed previously and only 20 to 27 % enrichment was observed in top 5 % of the list. 
However, CG3 identified only 2 % active compounds in 5 % screened library. In top 5 % of 
ranked library 50, 54 and 59 % enrichment were given by OECS, CGT and CG2, resp. In 
10 % screened library, CGO and SG correctly ranked more than 70 % of active compounds. 
CGT and CG2 found >64 % active hits in top 10 % list. OECS and PLP achieved 58 and 40 % 
enrichment, resp. FRED_CS and GOLD score showed similar results with more than 20 % 
enrichment. SS identified only 36 % active hits. The performance of CG3 was poor as ob-
served in case of M48. The results indicate that CGO and SG performed well, while CGT, 
CG2 and OECS were also good as compared to the rest of scoring functions.
1PY2. – On 1PY2, SG, CGO and CG2 successfully identified more than 60 % known 
inhibitors in top 1 % of the screened library. OECS showed more than 50 % enrichment. 
The performance of CG3, GOLD score and Surflex score was poor; each of them identified 
less than 8 % of actives. The scoring prediction of FRED_CS and SS was same with 17 and 
21 % enrichment, resp. CGT and PLP identified >30 % active hits. In top 5 % of library, the 
enrichment of CGO and SG significantly exceeded > 70 %. CG2 and OECS achieved 79 and 
68 % enrichment, resp. The performance of CGT, SS and PLP was similar; each of them 
showed > 50 % enrichment. The success rate of CG3, FRED_CS, GOLD score and Surflex 
score was < 20 % and did not reached the docking success threshold.
In 10 % of the screened library, CGO, CG2 and SG showed 80, 81 and 87 % enrichment, 
resp. The success rate of OECS and PLP ranged from 50 to over 70 %. CGT correctly identi-
fied 56 % active compounds, however, CG3 and GOLD score showed more than 20 % enrich-
ment. FRED_CS, SS and Surflex score identified <30 % hits. It was observed that some of 
the scoring functions including CGO and OECS consistently returned with more than 50 % 
success rate in top 10 % list, while SG efficiently yielded > 75 % hit rate in this cut off. In 
contrast, CG2 exceeded the docking success rate compared to CG3 for each receptor. The 
docking success rate of CG2 on 1M48 was < 35 % while it drastically improved with > 60 % 
on 1PW6 and > 80 % hit rate on 1PY2. Similarly, CGT returned with enrichment < 30 % on 
1M48, while the success rate came to around 60 % on 1PW6 and 1PY2. The performance of 
CG3, FRED_CS, SS, GOLD score and Surflex score was unsatisfactory. The performance of 
PLP was inconsistent, on 1M48 it showed 51 % hit rate, which decreased to 40 % on 1PW6. 
However, the success rate drastically improved from 40 to over 70 % on 1PY2 in 10 % 
screened list.
Binder/non-binder separation
In order to check the consistency of our applied scoring functions, docking results 
were also analyzed in terms of ROC curves. The AUC values are tabulated in Table V. 
Fig. 4 shows the ROC curves for all three protein complexes with each of the scoring func-
tions studied herein.
1M48 – Fig. 4a shows that CG3, FRED_CS, CG2, CGT and SS produced unsatisfactory 
results and failed to separate binder from non-binders appropriately. The AUCs are shown 
in Table V. Surflex score produced poor results with an AUC of 0.666. The performance of 
CGO, OECS, PLP and GOLD score was fair with AUC 0.7–0.8. SG efficiently separated 
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 binders from non-binders. The average AUC was 0.936. SG uses Gaussian function to 
 represent the shapes of molecules. This led to the conclusion that shape based scoring 
function can be reasonable to find inhibitors for protein-protein interfaces.
1PW6. – The performance of CGO was the same as observed in the case of 1M48 which 
returned with fair results. CGT showed poor results with AUC of 0.697, while CGT failed to 
differentiate between known actives from decoys. The performance of CG2 was improved 
and it returned with fair results. The performance of CG3 was insignificant throughout the 
VS step. It was observed that CG2 outperformed CG3 during VS. The performance of 
FRED_CS, SS and Surflex score was unsatisfactory, and GOLD score and PLP showed poor 
result with calculated AUC of 0.6–0.66. OECS and CGT showed fair results. SG was out-
standing in separating active compounds from non-binders with the calculated AUC 0.8–0.9. 
Fig. 4b represents the calculated ROC curve for all scoring functions applied on 1PW6.
1PY2. – The performance of CGO on 1PY2 was improved with AUC 0.859. CGT and SS 
also resulted with fair AUC (Fig. 4c). However, CG3, FRED_CS, GOLD score and Surflex 
score showed unsatisfactory results as compared to other scoring functions. OECS and 
PLP significantly differentiated between binders and non-binders and returned with good 
AUC, i.e., 0.845 and 0.836, resp. The results show that SG consistently produced excellent 
results and efficiently identified known actives from a pool of decoys. Among the nine 
scoring functions of FRED, SG and CGO were sufficient enough for VS, while CG3 and 
FRED_CS proved to be unsuitable for VS of IL-2 inhibitors. In this study CG2 was found to 
be better than CG3. The VS performance of Surflex dock and GOLD was also unsatisfac-
tory. The sequential use of ROCs led us to know that SG and CGO may be considered as a 
quick way to identify hits.
The average AUC was calculated to find out which scoring functions are appropriate 
for all three protein setups. SG outperformed all the scoring functions in discriminating 
binders and non-binders. The performance of CGO, OECS, PLP and CG2 was relatively 
fair, while CG3, FRED_CS and Surflex-dock failed to discriminate known active com-
pounds from decoys. CGT and SS performed poorly with an average AUC of 0.6–0.7 (Table 
V). The results clearly show the effectiveness of SG in finding active compounds in the top 
of the screened library and efficiently differentiating binders from non-binders.
CONCLUSIONS
IL-2 is involved in protein-protein interactions (PPIs) and play major role in cell deve-
lopment. Finding small molecules that modulate PPIs continues to be a major challenge for 
drug discovery. With the aim to establish effective VS protocol for IL-2, the feasibility of 
FRED, GOLD, MOE and Surflex-Dock with multiple scoring functions was assessed. The 
pose prediction performance of Surflex-Dock was outstanding followed by FRED and 
GOLD with GOLD score. We identified that two scoring functions namely SG and CGO 
were the best in the selection of known inhibitors in top 1, 5 and 10 % of the screened 
 library and in differentiating between binders and non-binders. In conclusion, a compre-
hensive assessment of widely used docking/scoring methods was conducted and an effec-
tive VS protocol was set up for the screening of IL-2 inhibitors, which will be used to 
identify novel IL-2 inhibitors.
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Abbreviations, acronyms, symbols. – AHB – alpha HB, AdG – affinity dG, APMI – alpha PMI, ASP 
– Astex Statistical Potential, AT – alpha triangle, AUC – area under the curve, CADD – Computer 
Aided Drug Design, Chemgauss 2, CG3 – Chemgauss 3, CS – ChemScore, CGO – Chemical Gaussian 
Overlay, CGT – Chemical Gaussian Tanimoto, %EF – percentual enrichment factor, FRED – Fast Rig-
id Exhaustive Docking, GA – Genetic Algorithm, GOLD – Genetic Optimization for Ligand Docking, 
HIC – Hammerhead Incremental Construction, IL-2 – Interleukin-2, IL-2R – IL-2 receptor, IC50 – con-
centration for 50 % inhibition, LdG – London dG, MMFF94 – molecular mechanics force field 94, MOE 
– Molecular Operating Environment, OECS –  OEChemScore, PDB – Protein Data Bank, PLP – piece-
wise linear potential, PMF – Potential of Mean Force, PPI – Protein-Protein Interactions, PT – proxy 
triangle, RB – number of rotatable bonds in ligand, RMSD – root mean square deviation, ROC–curve 
– receiver operating characteristics curve, Sc – selectivity, Sp – specificity, SS – ScreenScore, SG – 
Shapegauss, Th1 – T-helper 1, TM – triangle matcher, VS – virtual screening, ZINC – Zinc is not 
Commercial
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